CD274 and neoplasm: The efficacy of ICI appears to correlate with a presence of a pre-existing pro-inflammatory tumour microenvironment (TME) evidenced by higher immune cell infiltration or PD-L1 expression, whereas “immune desert” or “cold” tumours appear to respond less to ICI (TME) [8,9].